Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Parkinson's

The treatment of L-dopa associated effect fluctuations.

    • Congress Reports
    • Neurology
    • RX
    • Studies
  • 3 minute read

Parkinson’s patients suffer the most from effect fluctuations. However, it is not possible to predict when this phase begins due to the individual course of the disease. Several starting points have now been detected to maintain the effect of L-dopa. Interventions with COMT inhibitors are among the promising options to improve quality of life in the presence of drug fluctuations.

The introduction of L-dopa has revolutionized the armamentarium in neurology. Although it has been on the market for a long time, it remains the therapeutic gold standard and is considered the best-performing Parkinson’s drug that is well tolerated. Eventually, in the course of the disease, the use of L-dopa becomes necessary in almost every patient. Last but not least, it is a cost-effective intervention, affirmed Prof. Werner Poewe, MD, Innsbruck (A). The only drawback is the motor complications that occur during chronic L-dopa therapy. And these are not to be disregarded. Depending on the study base, the rate of affected individuals after five years of treatment ranges from 30-90%. In addition to L-dopa treatment, dosage, disease duration, and age are established risk factors.

A survey of 173 Parkinson’s disease patients treated with L-dopa and a ≥six-year duration of disease found that effect fluctuations, mood impairment, and drooling were among the three most bothersome symptoms. Effect fluctuations are subject to different pathogenetic factors. For example, dysphagia, variable gastric emptying due to gastroparesis, competition for intestinal absorption with dietary amino acids, or competition at the blood-brain barrier with dietary amino acids for BBB transport, and a short half-life may adversely affect L-dopa action. The short half-life can be varied using peripheral metabolism by aromatic L-amino acid decarboxylase (AADC) or catechol-O-methyltransferase (COMT).

COMT inhibition can mitigate effect fluctuations

The first COMT inhibitors were approved in the late 20th century. Tolcapone is peripherally and centrally effective, but now used only as a second-line agent because of its hepatotoxicity. In this case, close monitoring is obligatory, the expert emphasized. Entacapone is only peripherally effective and thus weaker than tolcapone, but does not exhibit hepatotoxicity. The introduction of opicapone then provided the desired improved effect without toxicity. This agent is a peripherally acting, selective COMT inhibitor with very high binding affinity and a slow dissociation rate of the opicapone COMT complex. Due to the long duration of action, once-daily application is sufficient.

Studies have shown that off-time could be reduced by more than an hour on average. In 37% of those affected, the reduction was even ≥2 hours. Dyskinesia was the most common adverse effect, which was well controlled by L-dopa dose reduction. In addition, early use seems to make sense in the presence of effect fluctuations, Poewe summarized.

Congress: FomF Neurology Update

 

Further reading:

  • Goetz, et al: Mov Disord 2002; 17(Suppl 4): 1-166.
  • Poewe, et al: Neurology 1986; 36(11): 1528.
  • Schrag, et al: Brain 2000; 123(Pt 11): 2297.
  • Quinn, et al: Mov Disord 1987; 2(2): 73.
  • Politis, et al: Mov Disord 2010; 25: 1646-1651.
  • Poewe, et al: Clin Interv Aging 2010; 5: 229-238.
  • Fox, et al: Mov Disord 2018; 26(Suppl 3): 2.
  • Rocha, et al: Br J Clin Pharmacol 2013; 76: 763-775.
  • Almeida, et al: Clin Pharmacokinet 2013: 52: 139-151.
  • Ferreira, et al: Eur J Neurol 2019; 26: 953-960.

 

InFo NEUROLOGY & PSYCHIATRY 2022; 20(3): 26.

Autoren
  • Leoni Burggraf
Publikation
  • InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
  • COMT inhibitors
  • L-Dopa
  • Parkinson's
Previous Article
  • Systemic Lupus Erythematosus

New weapons in the fight against SLE

  • Allergology and clinical immunology
  • Congress Reports
  • Dermatology and venereology
  • General Internal Medicine
  • Rheumatology
  • RX
  • Studies
View Post
Next Article
  • Obesity

Kilo tumbling in the family doctor’s office

  • Congress Reports
  • Endocrinology and Diabetology
  • General Internal Medicine
  • Nutrition
  • Prevention and health care
  • RX
  • Studies
View Post
You May Also Like
View Post
  • 30 min
  • Chemsex - MSM, sex, chrystal meth & co.

Medical and psychosocial perspectives

    • CME continuing education
    • General Internal Medicine
    • Infectiology
    • Pharmacology and toxicology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • RX
View Post
  • 3 min
  • Bladder cancer

Tuberculosis vaccination reduces recurrences

    • Congress Reports
    • Oncology
    • Pneumology
    • Prevention and health care
    • RX
    • Studies
    • Urology
View Post
  • 4 min
  • Oral JAK-i in atopic dermatitis

Benefits and risks: What does the current data say?

    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • RX
    • Studies
View Post
  • 17 min
  • Sleep-wake disorders in pneumology practice

Patience, knowledge and persistence in therapy

    • CME continuing education
    • General Internal Medicine
    • Neurology
    • Pneumology
    • RX
View Post
  • 9 min
  • Chronic lung diseases

Sarcopenia and malnutrition in the context of pneumological rehabilitation

    • CME continuing education
    • General Internal Medicine
    • Geriatrics
    • Nutrition
    • Pneumology
    • RX
    • Sports Medicine
    • Studies
View Post
  • 19 min
  • Cardiovascular risk and obesity

Pathomechanisms, secondary prevention and treatment options

    • Cardiology
    • CME continuing education
    • Endocrinology and Diabetology
    • Nutrition
    • RX
    • Sports Medicine
    • Studies
    • Training with partner
View Post
  • 9 min
  • Oxidative stress and neurodegeneration

Insights and therapeutic strategies for Parkinson’s disease

    • Education
    • Neurology
    • Phytotherapy
    • RX
    • Studies
View Post
  • 4 min
  • Biologics for atopic dermatitis

Th2 cytokines in focus: proven and new targets

    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • Pharmacology and toxicology
    • RX
    • Studies
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
  • Dermatology News

    Zum Thema
Top CME content
  • 1
    Patience, knowledge and persistence in therapy
  • 2
    Sarcopenia and malnutrition in the context of pneumological rehabilitation
  • 3
    Medical and psychosocial perspectives
  • 4
    New nomenclature for non-alcoholic fatty liver disease
  • 5
    Examinations and considerations before therapy

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.